Human Metabotropic Glutamate Receptor 5 Antibodies Alter Receptor Levels and Behavior in Mice

Ann Neurol. 2022 Jul;92(1):81-86. doi: 10.1002/ana.26362. Epub 2022 Apr 25.

Abstract

Ophelia syndrome or encephalitis with antibodies against the metabotropic glutamate receptor 5 (mGluR5) manifests with behavioral changes, memory deficits, and anxiety. To study the antibody pathogenicity, mice received continuous cerebroventricular infusion of patients' or controls' immunoglobulin G (IgG) for 14 days, followed by a 15-day washout. The effects on hippocampal mGluR5 clusters were determined by confocal microscopy. Animals infused with patients' IgG, but not controls' IgG, showed memory impairment, increased anxiety, and decreased neuronal surface mGluR5 clusters. After antibody clearance, both behavioral and molecular changes reversed to baseline conditions. These findings support the pathogenicity of these antibodies in anti-mGluR5 encephalitis. ANN NEUROL 2022;92:81-86.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies
  • Encephalitis*
  • Humans
  • Immunoglobulin G
  • Memory Disorders
  • Mice
  • Neurons
  • Receptor, Metabotropic Glutamate 5*

Substances

  • Autoantibodies
  • Grm5 protein, mouse
  • Immunoglobulin G
  • Receptor, Metabotropic Glutamate 5
  • anti-mGluR5 autoantibody